The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men
Background: Sildenafil, a treatment for erectile dysfunction, is a specific phosphodiesterase type 5 (PDE 5) inhibitor that enhances nitric oxide (NO)-mediated vasodilation in the corpus cavernosum by inhibiting cyclic guanosine monophosphate breakdown. Since PDE 5 is widely expressed in the vasculature, we examined the hypothesis that sildenafil could enhance NO-mediated vasodilation in other vascular beds and improve endothelial function.
Methods: NO-mediated responses to acetylcholine (endothelium-dependent) and nitroglycerin (endothelium-independent) were measured in healthy men in the dorsal hand vein (n = 13), after the administration of either sildenafil 50 mg or placebo. Flow-mediated dilation of the brachial artery and forearm postischemic reactive hyperemia were measured before and after sildenafil 50 mg, isosorbide dinitrate 5 mg, and placebo in a double-blind, randomized, crossover study (n = 11).
Results: In the hand vein, sildenafil administration increased sensitivity to local nitroglycerin. The 50% effective dose decreased approximately 4-fold from 13.5 ng/min (range, 6.9-26.6 ng/min) to 2.7 ng/min (range, 1.1-6.4 ng/min) (P =.025). Sildenafil decreased the maximum venoconstriction induced by phenylephrine from 81% +/- 3% to 74% +/- 3% (P =.025). Sildenafil did not significantly affect the maximal venodilatory response to acetylcholine (35% +/- 7% after placebo versus 32% +/- 8% after sildenafil) (P =.7). In the arterial vasculature, flow-mediated dilation before (2.4% +/- 1%) and after (2.8% +/- 1.4%) sildenafil (P =.8) and postischemic reactive hyperemia area under the curve before (1807 +/- 393 mL. min. s/100 mL) and after (1467 +/- 257 mL. min. s/100 mL) sildenafil were not different (P =.8). Resting heart rate, blood pressure, and resting brachial artery diameter were unchanged after sildenafil administration. Isosorbide dinitrate, an endothelium-independent vasodilator, caused a significant increase in resting brachial artery diameter from 0.53 +/- 0.01 cm to 0.56 +/- 0.02 cm (P =.005), without altering flow-mediated dilation.
Conclusions: In healthy men sildenafil increased sensitivity to nitroglycerin, an exogenous NO donor, approximately 4-fold but did not affect endothelium-dependent, NO-mediated responses in either the hand vein or forearm vasculature. Differential vascular responses to sildenafil may localize its enhancement of endogenous NO-mediated vasodilation to vascular beds such as the corpus cavernosum.
Similar articles
Vardi Y, Appel B, Ofer Y, Greunwald I, Dayan L, Jacob G. Vardi Y, et al. J Urol. 2009 Dec;182(6):2850-5. doi: 10.1016/j.juro.2009.08.025. Epub 2009 Oct 17. J Urol. 2009. PMID: 19837434 Clinical Trial.
Vlachopoulos C, Tsekoura D, Alexopoulos N, Panagiotakos D, Aznaouridis K, Stefanadis C. Vlachopoulos C, et al. Am J Hypertens. 2004 Nov;17(11 Pt 1):1040-4. doi: 10.1016/j.amjhyper.2004.06.027. Am J Hypertens. 2004. PMID: 15533731 Clinical Trial.
Parker JD, Bart BA, Webb DJ, Koren MJ, Siegel RL, Wang H, Malhotra B, Jen F, Glue P. Parker JD, et al. Crit Care Med. 2007 Aug;35(8):1863-8. doi: 10.1097/01.CCM.0000269371.70738.30. Crit Care Med. 2007. PMID: 17522570 Clinical Trial.
Harris A, Kagemann L, Ehrlich R, Ehrlich Y, López CR, Purvin VA. Harris A, et al. Br J Ophthalmol. 2008 Apr;92(4):469-73. doi: 10.1136/bjo.2007.131789. Br J Ophthalmol. 2008. PMID: 18369062 Review.
Jackson G. Jackson G. Int J Clin Pract. 2001 Apr;55(3):183-8. Int J Clin Pract. 2001. PMID: 11351772 Review.
Cited by 14 articles
Ross C, Szczepanek K, Lee M, Yang H, Peer CJ, Kindrick J, Shankarappa P, Lin ZW, Sanford JD, Figg WD, Hunter KW. Ross C, et al. Mol Cancer Res. 2020 Sep;18(9):1278-1289. doi: 10.1158/1541-7786.MCR-20-0046. Epub 2020 Jun 8. Mol Cancer Res. 2020. PMID: 32513899 Free PMC article.
Carter EA, Lohse K, Sheel W, Koehle M. Carter EA, et al. BMJ Open Sport Exerc Med. 2019 Mar 29;5(1):e000526. doi: 10.1136/bmjsem-2019-000526. eCollection 2019. BMJ Open Sport Exerc Med. 2019. PMID: 31191974 Free PMC article.
Pauls MM, Moynihan B, Barrick TR, Kruuse C, Madigan JB, Hainsworth AH, Isaacs JD. Pauls MM, et al. J Cereb Blood Flow Metab. 2018 Feb;38(2):189-203. doi: 10.1177/0271678X17747177. Epub 2017 Dec 19. J Cereb Blood Flow Metab. 2018. PMID: 29256324 Free PMC article.
Kellawan JM, Limberg JK, Scruggs ZM, Nicholson WT, Schrage WG, Joyner MJ, Curry TB. Kellawan JM, et al. J Appl Physiol (1985). 2018 Feb 1;124(2):276-282. doi: 10.1152/japplphysiol.00483.2017. Epub 2017 Oct 5. J Appl Physiol (1985). 2018. PMID: 28982942 Free PMC article.
Aydin S, Kuloglu T, Aydin S, Yardim M, Azboy D, Temizturk Z, Kalkan AK, Eren MN. Aydin S, et al. Cardiovasc J Afr. 2017 Nov/Dec 23;28(6):389-396. doi: 10.5830/CVJA-2017-025. Epub 2017 Aug 31. Cardiovasc J Afr. 2017. PMID: 28906529 Free PMC article.
